Aug 8, 2018
NIH has issued four Funding Opportunity Announcements (FOAs) for FY 2018 and beyond that solicit investigator-initiated projects within the Regenerative Medicine Innovation Project (RMIP) Program. These solicitations were informed by a multi-disciplinary, multi-sector Roundtable Workshop that NIH convened in December 2017 to explore issues related to product development, regulatory science, and clinical applications. The FOAs include both funding for clinical trials, as well as preclinical, late stage IND or IDE enabling studies. The totality of funds available for these awards collectively is up to $28 million. NIH anticipates making up to 15 awards in total under all the FOAs combined. Awards are expected to be made in April 2019.
Funding Opportunity Announcements (FOAs) are available at: https://www.nih.gov/rmi/funding-opportunities.
RMIP Investigator-Initiated Studies (U01 – Clinical Trial Not Allowed): https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-030.html
RMIP Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required): https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-031.html
RMIP (UT2 Small Business Technology Transfer Cooperative Agreemen)t:https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-031.html.
RMIP Small Business Innovation Research Cooperative Agreement:https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-035.html.
Per the mandate under the 21st Century Cures Act, responsive applications will propose clinical research involving adult stem cells. Responsive applications may propose, for example, research on biologics (e.g., growth factors, cytokines) and biomaterials (e.g., extracellular matrix, scaffolds) that stimulate host adult stem cell growth, proliferation, differentiation, and function or otherwise directly act upon adult stems cells to support innate host healing mechanisms, treat disease, and/or restore function.
Please feel free to contact us at firstname.lastname@example.org with any questions.
Jul 23, 2018
The Chad Vezina group has published a new paper in the American Journal of Physiology-Renal Physiology, Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots., describing a new tool for objective, consistent, and rapid analysis of mouse void spot assay (VSA) data. Void Whizzard is a FIJI (ImageJ) plugin that packages macros for image straightening and cropping, background subtraction and thresholding, spotfinding and determination of area, volume and quantity.
Apr 13, 2018
We are happy to release the new website for the latest phase of GUDMAP, GUDMAP3. As of April 15, 2018, the website now reflects an updated, clean design and a brand new browsing interface. The GUDMAP repository has also been integrated with the new kidney repository from the ReBuilding a Kidney (RBK) Consortium, with more new protocols, antibody validation data and sequencing data.
Click any of the data links on the homepage or in the navigation bar (under the “Data” menu) and you’ll enter the new Data Browser.
The GUDMAP Hub has been working hard to update the underlying data model to provide more linkages between data, better vocabulary integration and improved visualizations. We are still putting the finishing touches on some of the new data features and visualizations so expect the website to continue to evolve.
We’ve made a few videos to help you get acquainted with the new site. Start with the general overview video, then continue for video tutorials by data type. More videos will be added as we continue to develop GUDMAP as an unparalleled resource for genitourinary research.